Skip to main content
Top
Published in: Annals of Surgical Oncology 11/2018

Open Access 01-10-2018 | Melanoma

Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery

Authors: Stanley P. Leong, MD, Max Wu, MD, Ying Lu, PhD, Donald M. Torre, BS, Anna von Bakonyi, LVN, Arianna M. Ospina, BS, James D. Newsom, BS, William S. Luckett, MS, Christopher W. Soon, MD, Kevin B. Kim, MD, Mohammed Kashani-Sabet, MD

Published in: Annals of Surgical Oncology | Issue 11/2018

Login to get access

Abstract

Background

Preoperative imaging and intraoperative gamma probe (GP) localization is standard for identifying sentinel lymph nodes (SLNs) in melanoma patients. The aim of this prospective Institutional Review Board-approved study was to investigate whether an intraoperative portable gamma camera (PGC) improves SLN detection over the GP.

Methods

Lymphoscintigraphy and single photon emission computed tomography/computed tomography were performed after injection of 99mTc-Tilmanocept in melanoma patients (≥ 18 years, Breslow thickness ≥ 1.0 mm). A GP was used to localize the SLNs in each basin, which was explored by the GP to ensure that the operative field was < 10% counts of the hottest SLN. The PGC was then used after a negative GP screening. Any residual hotspots identified by the PGC were considered as additional SLNs and were removed following the 10% rule.

Results

Preoperative imaging of 100 patients identified 138 SLN basins, with 306 SLNs being identified by conventional surgery. The PGC localized 89 additional SLNs in 54 patients. Thus, the PGC identified an additional 23% of SLNs [95% confidence interval (CI) 18–27%]. Four of these 89 SLNs showed micrometastasis in four patients, in two of whom the only tumor-positive SLN was identified by the PGC, preventing two false-negative cases. Thus, the null hypothesis that the PGC did not detect additional positive SLNs was rejected (p = 0.000). The overall SLN positive rate was 9.9% (39/395, 95% CI 6–12), and the overall patient positive rate was increased using the PGC, from 25 to 27% (27/100).

Conclusions

Intraoperative PGC imaging yielded additional SLNs in a significant number of patients over GP alone. Identification of these additional SLNs resulted in upstaging of four patients with two patients being converted from a negative to a positive status, thus, preventing two false-negative cases.
Literature
1.
go back to reference Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.CrossRef Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.CrossRef
2.
go back to reference Wong SL, Faries MB, Kennedy EB, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018;36:399–413.CrossRef Wong SL, Faries MB, Kennedy EB, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018;36:399–413.CrossRef
3.
go back to reference Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472–492. Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472–492.
4.
go back to reference Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599–609.CrossRef Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599–609.CrossRef
5.
go back to reference Hellingman D, de Wit-van der Veen LJ, Klop WMC, Olmos RAV. Detecting near-the-injection-site sentinel nodes in head and neck melanomas with a high-resolution portable gamma camera. Clin Nucl Med. 2015;40:e11–e16.CrossRef Hellingman D, de Wit-van der Veen LJ, Klop WMC, Olmos RAV. Detecting near-the-injection-site sentinel nodes in head and neck melanomas with a high-resolution portable gamma camera. Clin Nucl Med. 2015;40:e11–e16.CrossRef
6.
go back to reference Vidal-Sicart S, Paredes P, Zanón G, et al. Added value of intraoperative real-time imaging in searches for difficult-to-locate sentinel nodes. J Nucl Med. 2010;51:1219–1225.CrossRef Vidal-Sicart S, Paredes P, Zanón G, et al. Added value of intraoperative real-time imaging in searches for difficult-to-locate sentinel nodes. J Nucl Med. 2010;51:1219–1225.CrossRef
7.
go back to reference Stoffels I, Poeppel T, Boy C, et al. Radio-guided surgery: advantages of a new portable γ-camera (Sentinella®) for intraoperative real time imaging and detection of sentinel lymph nodes in cutaneous malignancies. J Eur Acad Dermatology Venereol. 2012;26:308–313.CrossRef Stoffels I, Poeppel T, Boy C, et al. Radio-guided surgery: advantages of a new portable γ-camera (Sentinella®) for intraoperative real time imaging and detection of sentinel lymph nodes in cutaneous malignancies. J Eur Acad Dermatology Venereol. 2012;26:308–313.CrossRef
8.
go back to reference Bluemel C, Herrmann K, Giammarile F, et al. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging. 2015;42:1750–1766.CrossRef Bluemel C, Herrmann K, Giammarile F, et al. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging. 2015;42:1750–1766.CrossRef
9.
go back to reference McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol. 2001;8:192–197.CrossRef McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol. 2001;8:192–197.CrossRef
10.
go back to reference Liu L-C, Parrett BM, Jenkins T, et al. Selective sentinel lymph node dissection for melanoma: importance of harvesting nodes with lower radioactive counts without the need for blue dye. Ann Surg Oncol. 2011;18:2919–2924.CrossRef Liu L-C, Parrett BM, Jenkins T, et al. Selective sentinel lymph node dissection for melanoma: importance of harvesting nodes with lower radioactive counts without the need for blue dye. Ann Surg Oncol. 2011;18:2919–2924.CrossRef
11.
go back to reference Sánchez F, Fernández MM, Giménez M, et al. Performance tests of two portable mini gamma cameras for medical applications. Med Phys. 2006;33:4210–4220.CrossRef Sánchez F, Fernández MM, Giménez M, et al. Performance tests of two portable mini gamma cameras for medical applications. Med Phys. 2006;33:4210–4220.CrossRef
12.
go back to reference Hastie TJ, Pregibon D. Generalized linear models. Chapter 6. In: Chambers JM, Hastie TJ (eds). Statistical models in S. Wadsworth & Brooks/Cole; 1992. Hastie TJ, Pregibon D. Generalized linear models. Chapter 6. In: Chambers JM, Hastie TJ (eds). Statistical models in S. Wadsworth & Brooks/Cole; 1992.
13.
go back to reference Olcott P, Pratx G, Johnson D, Mittra E, Niederkohr R, Levin CS. Clinical evaluation of a novel intraoperative handheld gamma camera for sentinel lymph node biopsy. Phys Medica Eur J Med Phys. 2014;30(3):340–345. Olcott P, Pratx G, Johnson D, Mittra E, Niederkohr R, Levin CS. Clinical evaluation of a novel intraoperative handheld gamma camera for sentinel lymph node biopsy. Phys Medica Eur J Med Phys. 2014;30(3):340–345.
14.
go back to reference Morton DL, Wen DR, Wong, al et. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399.CrossRef Morton DL, Wen DR, Wong, al et. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399.CrossRef
15.
go back to reference Testori A, De Salvo GL, Montesco MC, et al. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 Patients (SOLISM–IMI). Ann Surg Oncol. 2009;16:2018–2027.CrossRef Testori A, De Salvo GL, Montesco MC, et al. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 Patients (SOLISM–IMI). Ann Surg Oncol. 2009;16:2018–2027.CrossRef
16.
go back to reference Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol. 2006;13:1655–1663.CrossRef Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol. 2006;13:1655–1663.CrossRef
17.
go back to reference Jones EL, Jones TS, Pearlman NW, al et. Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg. 2013;148:456–461.CrossRef Jones EL, Jones TS, Pearlman NW, al et. Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg. 2013;148:456–461.CrossRef
18.
go back to reference Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–1317.CrossRef Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–1317.CrossRef
19.
go back to reference Chao C, Wong SL, Ross MI, et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg. 2002;184:520–524.CrossRef Chao C, Wong SL, Ross MI, et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg. 2002;184:520–524.CrossRef
20.
go back to reference Valsecchi ME, Silbermins D, de Rosa N, Wong SL, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol. 2011;29:1479–1487.CrossRef Valsecchi ME, Silbermins D, de Rosa N, Wong SL, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol. 2011;29:1479–1487.CrossRef
21.
go back to reference Tardelli E, Mazzarri S, Rubello D, et al. Sentinel lymph node biopsy in cutaneous melanoma: standard and new technical procedures and clinical advances. A systematic review of the literature. Clin Nucl Med. 2016;41:e498–e507.CrossRef Tardelli E, Mazzarri S, Rubello D, et al. Sentinel lymph node biopsy in cutaneous melanoma: standard and new technical procedures and clinical advances. A systematic review of the literature. Clin Nucl Med. 2016;41:e498–e507.CrossRef
22.
go back to reference Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211–2222.CrossRef Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211–2222.CrossRef
23.
go back to reference Lee DY, Huynh KT, Teng A, et al. Predictors and survival impact of false-negative sentinel nodes in melanoma. Ann Surg Oncol. 2016;23:1012–1018.CrossRef Lee DY, Huynh KT, Teng A, et al. Predictors and survival impact of false-negative sentinel nodes in melanoma. Ann Surg Oncol. 2016;23:1012–1018.CrossRef
24.
go back to reference Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377:1824–1835.CrossRef Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377:1824–1835.CrossRef
25.
go back to reference Long GV, Hauschild A, Santinami M, et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N Engl J Med. 2017;377:1813–1823.CrossRef Long GV, Hauschild A, Santinami M, et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N Engl J Med. 2017;377:1813–1823.CrossRef
26.
go back to reference Leong SPL, Kim J, Ross M, et al. A phase 2 study of 99mTc-Tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol. 2011;18:961–969.CrossRef Leong SPL, Kim J, Ross M, et al. A phase 2 study of 99mTc-Tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol. 2011;18:961–969.CrossRef
27.
go back to reference Sondak VK, King DW, Zager JS, et al. Combined analysis of phase III trials evaluating [99mTc] Tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol. 2013;20:680–688.CrossRef Sondak VK, King DW, Zager JS, et al. Combined analysis of phase III trials evaluating [99mTc] Tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol. 2013;20:680–688.CrossRef
28.
go back to reference Leong SPL, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000;7:361–366.CrossRef Leong SPL, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000;7:361–366.CrossRef
Metadata
Title
Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery
Authors
Stanley P. Leong, MD
Max Wu, MD
Ying Lu, PhD
Donald M. Torre, BS
Anna von Bakonyi, LVN
Arianna M. Ospina, BS
James D. Newsom, BS
William S. Luckett, MS
Christopher W. Soon, MD
Kevin B. Kim, MD
Mohammed Kashani-Sabet, MD
Publication date
01-10-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 11/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6685-1

Other articles of this Issue 11/2018

Annals of Surgical Oncology 11/2018 Go to the issue